trial

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk

NCTId NCT05131035
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 54 (estimated)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2026-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
54 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2021-10-28
Primary completion
2026-05-31
Eligibility
ALL · 14 Years · 20 Years

Interventions & indications

Drugs
SCORES (Specific COgnitive Remediation with Support)

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Ricardo E Carrion, Ph.D.Principal Investigator

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
54
Phase
NA
Primary Completion Date
2026-05-31
Status
RECRUITING
relationships
The graph out of here
drug
SCORES (Specific COgnitive Remediation with Support)
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Prodromal Schizophrenia
indication
Schizotypal Personality Disorder
indication
Psychosis
indication
investigator
Ricardo E Carrion, Ph.D.
person